Canton Strategic Holdings (CNTN) Enterprise Value (2020 - 2026)
Canton Strategic Holdings posted quarterly Enterprise Value of -$41.5 million for Q1 2026, down 3760.12% year-on-year from $1.1 million in Q1 2025, and down 143.84% on a QoQ basis from -$17.0 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Enterprise Value data on file, last reported at -$41.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 3760.12% year-over-year to -$41.5 million; the trailing twelve-month figure through Mar 2026 stood at -$41.5 million (down 3760.12% YoY), and the FY2025 full-year result was -$17.0 million, down 378.53% from the prior year.
- Enterprise Value for Q1 2026 stood at -$41.5 million, down from -$17.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q1 2025 and bottomed at -$41.5 million in Q1 2026.
- The 5-year median for Enterprise Value is -$7.6 million (2022), against an average of -$8.8 million.
- The widest annual swing landed in 2022, when Enterprise Value slumped 149361.29%; it then soared 87.23% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$6.5 million in 2022, then slumped by 67.96% to -$10.9 million in 2023, then jumped by 67.45% to -$3.6 million in 2024, then slumped by 378.53% to -$17.0 million in 2025, then tumbled by 143.84% to -$41.5 million in 2026.
- The last three Enterprise Value figures came in at -$41.5 million (Q1 2026), -$17.0 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -41.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.53 Mn |
| Dec 31, 2025 | -17.03 Mn |
| Sep 30, 2025 | -7.61 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -8.43 Mn |
| Dec 31, 2023 | -10.94 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -3.90 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -6.51 Mn |
| Sep 30, 2022 | -7.60 Mn |
| Jun 30, 2022 | -9.48 Mn |
| Mar 31, 2022 | -11.12 Mn |
| Dec 31, 2021 | -4,356.00 |
| Sep 30, 2021 | -45,095.00 |
| Jun 30, 2021 | -29,271.00 |
| Mar 31, 2021 | -22,507.00 |
| Dec 31, 2020 | -191,852.00 |